![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 9/20 | |
A61K 9/28 | |||
A61K 9/48 | |||
A61K 9/50 | |||
A61K 31/40 | |||
A61K 31/403 | |||
A61K 31/60 | |||
A61K 31/505 | |||
A61K 31/616 | |||
A61P 9/00 |
(11) | Number of the document | 2986281 |
(13) | Kind of document | T |
(96) | European patent application number | 14728940.9 |
Date of filing the European patent application | 2014-06-05 | |
(97) | Date of publication of the European application | 2016-02-24 |
(45) | Date of publication and mention of the grant of the patent | 2016-12-21 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/EP2014/061735 |
Date | 2014-06-05 |
(87) | Number | WO 2014/195421 |
Date | 2014-12-11 |
(30) | Number | Date | Country code |
13170909 | 2013-06-06 | EP |
(72) |
MARTIN SANZ, Pablo, ES
URBANO HURTADO, Javier, ES
|
(73) |
Ferrer Internacional, S.A.,
Gran Via Carles III 94, 08028 Barcelona,
ES
Fundaci n Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC), Melchor Fernįndez Almagro, 3, 28029 Madrid, ES |
(54) | ORAL FORMULATION FOR THE TREATMENT OF CARDIOVASCULAR DISEASES |
ORAL FORMULATION FOR THE TREATMENT OF CARDIOVASCULAR DISEASES |